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Background
Little is known about the kinetics of anti-H5 neutraliz-
ing antibodies in naturally H5N1-infected patients with
severe clinical illness or asymptomatic infection. These
data are essential for the design and interpretation of
sero-epidemiological studies which are crucial to moni-
tor the extent of asymptomatic or clinically mild H5N1
illness among humans or to identify risk factors asso-
ciated with human contamination.
Methods
Using H5N1 microneutralisation (MN) and H5-pseudo-
type particle-based microneutralisation assays (H5pp)
we analyzed sera sequentially obtained from 11 severely
ill patients diagnosed by RT-PCR (follow-up range 1 –
139 weeks of disease onset) and 31 asymptomatically
infected individuals detected in a sero-epidemiological
study after exposure to H5N1 virus (follow-up range: 1-
2 month – 11 months after exposure).
Results
Antibody kinetics measured by H5pp were similar to
that from MN assay with a good correlation between
the titers measured by the two methods (Spearman’s
correlation coefficient of 0.79, p<0.001). Of 44 sera from
11 patients with H5N1 disease, 70% tested positive by
MN (antibody titre ≥80) after 2 weeks and 100% were
positive by 3 weeks after disease onset. The geometric
mean MN titers in severely ill patients were 540 at 1-2
months and 173 at 10-12 months and thus were higher
than the titers from asymptomatic individuals (149 at
1-2 months, 62.2 at 10-12 months). Fractional polyno-
mial regression analysis demonstrated that in all severely
ill patients, positive titers persisted beyond 2 years of
disease onset, while 10 of 23 sera collected 10-11
months after exposure in asymptomatically infected
individuals tested negative.
Conclusion
We demonstrated a good correlation between the 2 tests
used, hence confirming the validity of the H5pp test as a
screening test in sero-epidemiological studies of H5N1
infection. Our data provide important novel insights
into the dynamics of serological responses in patients
with the full spectrum of clinical disease from severe
though mild to asymptomatic H5N1 infection. Indeed,
our results indicate that people with asymptomatic
H5N1 infection have lower H5N1 antibody titers
compared to those with severe illness and that in many
asymptomatically infected patients the antibody
titer decreased to levels below the threshold of
positivity within one year. Hence delayed community
sero-prevalence studies forH 5 N 1m a yu n d e r e s t i m a t e
the true burden of human infection.
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